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Abstract 
Background: The four-dimensional symptom questionnaire (4DSQ) is an originally Dutch self-report questionnaire 
that has been developed in primary care to distinguish non-specific general distress from depression, anxiety and 
somatization. In order to produce the appropriate translated Russian version the process of linguistic validation has 
been initiated. This process has been done according to the “Linguistic Validation Manual for Health Outcome Assess-
ments” developed by MAPI institute.
Objective: To produce the appropriate Russian version of the 4DSQ that is conceptually and linguistically equivalent 
to the original questionnaire.
Methods: The original Dutch version of the 4DSQ was translated by one translator into Russian. The validated English 
version of the 4DSQ was translated by another translator into Russian without mutual consultation. The consensus 
version was created based on two translated versions. After that the back translation was performed to Dutch, some 
changes were implemented to the consensus Russian version and the second target version was developed based 
on these results. The second target version was sent to an appropriate group of reviewers. Based on their comments, 
the second target version was updated. After wards this version was tested in patients during cognitive interview. 
The study protocol was approved by the Independent Interdisciplinary Ethics Committee on Ethical Review for Clini-
cal Studies, and in compliance with the Helsinki Declaration and ICH-GCP guidelines and local regulations. Enrolled 
patients provided written informed consent.
Results: After the process of forward and backward translation, consultant and developer’s comments, clinicians and 
cognitive review the final version of Russian 4DSQ was developed for assessment of distress, depression, anxiety and 
somatization.
Conclusion: The Russian 4DSQ as a result of translation procedures and cognitive interviews linguistically corre-
sponds to the original Dutch 4DSQ and could be assessed in psychometric validation for the further using in general 
practice.
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Background
The Russian language tools for the diagnoses of men-
tal disorders in general practice are presented as scales 
that assess levels of anxiety and depression, but there 
are very few questionnaires for the differential assess-
ment of non-specific reactions to stress and somatized 
mental disorders, including somatoform dysfunction of 
the autonomic nervous system. To identify such ques-
tionnaires, the foreign (non-Russian) literature was 
reviewed. The primary goal of the search we performed 
amongst international scales was to find the scale which 
includes assessment of multiple conditions (depres-
sion, anxiety, distress and somatization). The results of 
the search singled out the 4DSQ that was developed in 
1996 by the Dutch general practitioner B. Terluin [4]. 
This questionnaire was developed to identify the clini-
cal phenomena of distress and somatization and to dis-
tinguish these phenomena from depression and anxiety 
in primary health care settings; these phenomena are 
difficult to assess using other scales [2, 3]. The devel-
opment of descriptors of the questionnaire was based 
on data from ten studies that were conducted in vari-
ous primary care institutions in the Netherlands. The 
validity of the criteria was evaluated by comparing 
the 4DSQ scores with the clinical diagnoses of general 
practitioners and their opinions on the supposed som-
atizations and the standardized diagnoses of mental 
disorders.
The 4DSQ is a self-rated questionnaire for patients. The 
questionnaire consists of 50 items that assess symptom 
severities on subscales for distress, depression, anxiety 
and somatization within the previous 7-day period. The 
analysis of the responses allow for the determination of 
the nature of the predominant component in the struc-
ture of patients’ mental disorders [4]. The 4DSQ was 
clinically validated in the Netherlands, has passed an 
assessment of cross-cultural reliability in Poland and has 
shown good psychometric properties [5, 6, 7–9].
The brevity and simplicity of the questionnaire appears 
to be optimal for its application in the Russian popula-
tion of patients with somatoform dysfunction of the 
autonomic nervous system; thus we decided to perform a 
Russian-language validation of the 4DSQ.
The purpose of this study was to validate the 4DSQ 
in Russia in a sample of patients with somatoform auto-
nomic dysfunctions and verify its equivalence to the orig-
inal version. There are always risks that after translation 
the exact meaning of some points may be lost and cul-
tural differences may influence the interpretation of the 
questions. Therefore, there is a need to make sure that 
the Russian version measures the same as the original 
Dutch questionnaire.
Methods
In order to produce an appropriately translated Russian 
version the process of linguistic validation has been used. 
This process has been done according to the “Linguistic 
Validation Manual for Health Outcome Assessments” 
developed by MAPI institute (http://www.mapigroup.
com). The 4DSQ is available as a Dutch and English ver-
sion (Additional file 1), as well as a number of other lan-
guages (see http://www.emgo.nl/researchtools/4DSQ.
asp). The developer of the 4DSQ, Dr. Berend Terluin, took 
part in all steps of the process, except of those steps which 
are performed by qualified independent translators.
The purpose was to produce a Russian version of the 
questionnaire that is conceptually and linguistically 
equivalent to the source measure and allows data pooling 
and analysis/comparison across countries.
According to the “Linguistic Validation Manual for 
Health Outcome Assessments” the following steps for 
the linguistic validation from non-English language into 
another non-English language were performed:
  • Forward translation of the original Dutch question-
naire and of the English version.
  • Creating a consensus forward translation (version 
1.0).
  • Backward translation to Dutch.
  • Creating a second consensus translation (version 
2.0).
  • Clinical review (version 2.1).
  • Cognitive interviews.
  • Proofreading (final version).
Forward translations
Two qualified translators, both native Russian speakers, 
proficient in the source language and in English, living in 
the target country (Russia), with experience in the trans-
lation of medical and pharmaceutical documents, includ-
ing the questionnaires for patients and who have been 
briefed on the purpose of the work. The translators were 
provided by professional translation agency “Roid”, based 
in Moscow, Russia (http://www.roid.ru).
The original version of the 4DSQ in Dutch was trans-
lated by one translator into Russian. The validated Eng-
lish version of the 4DSQ was translated by another 
translator into Russian without mutual consultation.
The validated English version already existed (previ-
ously adapted into English). In order to facilitate the 
process and improve international harmonization (in 
agreement with the recommendations of MAPI insti-
tute), it was decided that Russian translation should be 
based on both the original Dutch and validated English 
versions.
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The consultant reviewed the two versions, compared 
them with the original, and established a Consensus ver-
sion 1.0 in consultation with the translators.
The consultant reported (in English) the translation 
decision to developer and process participants. Based on 
this discussion, the Consensus language version 1.0 was 
created.
The role of the consultant was to perform quality con-
trol for the translation performed. The consultant was 
an independent specialist, medical writer, Contract 
Research Organization employee.
Backward translation
It was agreed by all participants a priori that the developer 
of 4DSQ organized the backward translation of consensus 
Russian language version 1.0 into Dutch language in order 
to be in strictly compliance with MAPI recommendations 
[2012—Linguistic Validation Manual for Health Outcome 
Assessments (MAPI institute, new edition)] and thus to 
provide the high quality of review. A professional trans-
lation company “Translavic BV” (http://www.translavic.
com) performed backward translation of Russian Con-
sensus language version 1.0 of 4DSQ in Dutch for Berend 
Terluin to assess concordance between the back-trans-
lated version and the original Dutch version.
The developer compared the original version of 4DSQ 
and the backward translation into Dutch language of 
consensus target language version 1.0. For each item the 
developer analyzed the backward translation and deter-
mined whether it appropriately reflected the consensus 
target language version. All discrepancies were care-
fully examined, the developer described with consultant 
the findings and decided whether these discrepancies 
required modifications in the consensus target language 
version and suggested appropriate amendments. In 
order to facilitate the translation process the previously 
validated English version was used by consultant as the 
“mother” version instead of the original Dutch version.
During these procedures some critical points were dis-
covered (see Table 1) and the target Russian language ver-
sion 2.0 was developed. For example, in English version 
item 19 was translated as “Worry”, therefore it was trans-
lated in Russian as “Бecпoкoйcтвo”. During the process of 
backward translation this item was back-translated into 
“rusteloosheid” (Dutch), which means “restlessness” in 
English. The original item speaks of “piekeren” (Dutch).
According to the developer, this word describes a situ-
ation in which someone has to think constantly of some-
thing, usually something that is bothering the person a 
lot. Actually, this is not really thinking (as a deliberate 
activity of someone), it is more like thoughts running 
through one’s head all the time (often in circles, as people 
say), and these thoughts are difficult to stop or to control. 
The person wants to stop this “piekeren” but nevertheless 
it goes on and on, especially when someone tries to relax 
or fall asleep.
Going further, it was decided, in agreement with the 
developer, to use two different translations for item 19 in 
Russian version of the scale:
1. “нaзoйливыe тpeвoжныe мыcли”—“intrusive restless 
thoughts”.
2. “нaзoйливыe нeпpиятныe мыcли”—“intrusive annoy-
ing thoughts”.
These translations were discussed during clinician’s 
review step.
Clinician’s review
The target version 2.0 was sent to an appropriate group of 
reviewers including clinicians. The criteria for appropri-
ateness were: scientific degree, clinical trials experience, 
specialist in therapeutic neurology or psychiatrist/or spe-
cialist from Healthcare Regulatory system/or specialist 
from clinical trials ethics expertise.
Neurologists and psychiatrists participation in clini-
cians review process was justified by the fact that thera-
peutical neurologists and not general practitioners in 
fact treat the patients with the described above symp-
toms. General practitioners (GP) would be provided with 
the instrument for the deep analysis of those patients in 
order to involve GPs more deeply in diagnosis and treat-
ment after further psychometric validation of 4DSQ. 
Reviewers made comments, suggested changes in the 
translation, and returned it to the institute.
Created target version 2.1 was used for cognitive 
interview.
Cognitive interviews
Ten patients with diagnosis “Disorders of autonomic 
nervous system” (4 women and 6 men) in I.M. Sechenov 
First Moscow Medical State University’s clinic at mean 
age of 35.4  ±  12.54 (Mean  ±  SD) years (the minimum 
age of 19 years, the maximum age of 54 years) were inter-
viewed by the consultant Tatiana Pukhalskaya (MD, PhD, 
certified translator in English). The aim of this interview 
was to test the scale in patients group by means of asking 
them about questionnaire. The interview was structured 
in accordance with the protocol of cognitive interview.
The consultant tested the target version 2.1 on all sub-
jects during individual in-depth, face-to-face interviews.
During each interview, the consultant first asked the 
respondent to complete the questionnaire.
After completion, the consultant reviewed each item of 
the target version 2.1 with the subject and asked whether 
the subject encountered any difficulty while responding.
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The cognitive study was conducted during the period 
from July 2013 to December 2013.
If patient reported difficulties in any item of question-
naire completion, forward and backward translations 
were performed to analyze the origin of it.
It makes sense to note that four patients from the tar-
get population have paid their attention to item 21, con-
sidering the phrase “cмyтнoe чyвcтвo cтpaxa” (a vague 
feeling of fear), and offering to replace it with the words 
“нeoбъяcнимoe” or “нeocoзнaннoe” feeling of fear. How-
ever, it should be noted that the actual wording fully 
and the most adequately covers the translation of the 
validated English version of 4DSQ. Such difficulties have 
also occurred with items 28, 32, 36 and 38, but the actual 
wording fully and the most adequately covers the transla-
tion of the validated English version of 4DSQ:
Item 28—two patients did not understand the reference 
of the words “everything is meaningless”. The patients 
had decided that it refers to the treatment;
Item 32—three patients did not understand that the 
phrase “all this” refers to the previous questions;
Item 36—two patients did not understand the refer-
ence of the phrase “all it”, probably to the all the above 
mentioned;
Item 38—the word “thinking clearly” was not clear 
enough for two patients.
Based on the discussion of unclear items with the 
patients, consultant suggested that it seems appropri-
ate to reconsider the wording of the one which was 
unclear to four patients: the word “дypнoтa” (feeling 
light-headed) could be translated as “пpeдoбмopoчнoe 
cocтoяниe”.
This recommendation was implemented into the final 
Russian version of 4DSQ.
Results
Based on the results of forward and backward transla-
tion, consultant and developer’s comments, clinicians’ 
and cognitive review the final version of Russian 4DSQ 
was developed.
The further study for the psychometric validation 
based on linguistically validated Russian questionnaire 
was planned. In general, the translation process of the 
Russian version of the 4DSQ questionnaire development 
based on the Dutch questionnaire proved to be success-
ful. We suppose that the scheme of linguistic validation 
that we used could be used for other languages as well.
Discussion
After all steps of linguistic validation the Russian 4DSQ-
scales have demonstrated the same linguistic structure 
as the original Dutch scales. Therefore, we can propose 
that this version could be used in general practice as a 
diagnostic tool after psychometric validation. Anyway 
there is a need of study of 4DSQ’s potential in the large 
population, especially in regions.
Strengths and limitations
The main limitation is that this validation does not 
include psychometric validation which is required for the 
further scale recommendation in general practice.
Also the limitation of the study concerns the repre-
sentativeness of the sample of the Clinic of Nervous Dis-
eases of the First Moscow State Medical University (who 
participated in cognitive interview) for Russian speaking 
patients in general and small patients sample size. Rus-
sian speaking population is much differentiated in many 
ways, and we cannot entirely exclude the possibility that 
the study in some clinics in other regions would have dif-
ferent results.
When larger datasets in Russian speaking people will 
be available, future studies could provide analysis that is 
more detailed by more parameters and that could be the 
base for updated Russian version of the 4DSQ.
Conclusions
The Russian 4DSQ as a result of translation procedures 
and cognitive interview linguistically corresponds to the 
original Dutch 4DSQ and could be used in further stud-
ies and general practice.
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